Investors Buy Large Volume of Put Options on Questcor Pharmaceuticals (QCOR)
Shares of Questcor Pharmaceuticals (NASDAQ:QCOR) were the target of some unusual options trading on Tuesday. Stock traders purchased 11,353 put options on the company, Analyst RN reports. This is an increase of approximately 377% compared to the typical daily volume of 2,380 put options.
In other Questcor Pharmaceuticals news, Director Broadwood Partners Lp unloaded 306,400 shares of the stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $74.94, for a total transaction of $22,961,616.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Separately, analysts at Zacks reiterated a “neutral” rating on shares of Questcor Pharmaceuticals in a research note on Friday, January 24th. They now have a $68.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Questcor Pharmaceuticals presently has an average rating of “Buy” and a consensus target price of $76.67.
Shares of Questcor Pharmaceuticals (NASDAQ:QCOR) traded down 1.02% during mid-day trading on Tuesday, hitting $78.65. 3,146,643 shares of the company’s stock traded hands. Questcor Pharmaceuticals has a one year low of $26.80 and a one year high of $80.15. The stock’s 50-day moving average is $63.87 and its 200-day moving average is $61.72. The company has a market cap of $4.632 billion and a price-to-earnings ratio of 18.25.
Questcor Pharmaceuticals (NASDAQ:QCOR) last released its earnings data on Tuesday, February 25th. The company reported $1.67 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.66 by $0.01. The company had revenue of $243.00 million for the quarter, compared to the consensus estimate of $244.15 million. Analysts expect that Questcor Pharmaceuticals will post $5.47 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, April 25th. Investors of record on Friday, April 18th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.51%. The ex-dividend date of this dividend is Tuesday, April 15th.
Questcor Pharmaceuticals, Inc (NASDAQ:QCOR) is a biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.